CS logo
small CS logo
SPb SBIH "Clinical Rheumatological Hospital # 25"

Saint Petersburg, Russian Federation
Hospital in Saint Petersburg
Bol'shaya Pod'yacheskaya Ulitsa, 30, St Petersburg, 190068

About SPb SBIH "Clinical Rheumatological Hospital # 25"


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at SPb SBIH "Clinical Rheumatological Hospital # 25"


During the past decade, SPb SBIH "Clinical Rheumatological Hospital # 25" conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 11 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
2005-04-08
2009-09-07
Completed
829
Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD
2002-07-01
2003-03-01
Completed
141
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV
2003-07-01
2004-12-01
Terminated
80
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV
2003-06-01
2004-11-01
Terminated
180
Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
2006-04-01
2007-08-01
Completed
1,695
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer
2006-06-01
2013-10-01
Completed
372
Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
2004-06-01
2006-03-01
Terminated
Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial
2005-06-01
Completed

Rows per page:

1–100 of 784

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "SPb SBIH "Clinical Rheumatological Hospital # 25"" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "SPb SBIH "Clinical Rheumatological Hospital # 25"" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at SPb SBIH "Clinical Rheumatological Hospital # 25"


According to Clinical.Site data, the most researched conditions in "SPb SBIH "Clinical Rheumatological Hospital # 25"" are "Rheumatoid Arthritis" (5 trials), "Systemic Lupus Erythematosus" (3 trials), "Arthritis, Psoriatic" (2 trials), "Axial Spondyloarthritis" (2 trials) and "Active Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "SPb SBIH "Clinical Rheumatological Hospital # 25"" in a lesser frequency.

Clinical Trials Intervention Types at SPb SBIH "Clinical Rheumatological Hospital # 25"


Most popular intervention types in "SPb SBIH "Clinical Rheumatological Hospital # 25"" are "Drug" (11 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Guselkumab" (2 trials), "Ixekizumab" (2 trials), "Adalimumab" (1 trials) and "Adalimumab - GP2017" (1 trials). Other intervention names were less common.

Clinical Trials Genders at SPb SBIH "Clinical Rheumatological Hospital # 25"


The vast majority of trials in "SPb SBIH "Clinical Rheumatological Hospital # 25"" are 14 trials for "All" genders.

Clinical Trials Status at SPb SBIH "Clinical Rheumatological Hospital # 25"


Currently, there are NaN active trials in "SPb SBIH "Clinical Rheumatological Hospital # 25"". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in SPb SBIH "Clinical Rheumatological Hospital # 25", undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in SPb SBIH "Clinical Rheumatological Hospital # 25", 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status